Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction

Journal of Surgical Oncology

Volumn 92, Issue 2, 2005, Pages 116-123

  Wijnhoven, Bas P L ^a   Pignatelli, Massimo ^b   Dinjens, Winand N M ^a   Tilanus, Hugo W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Catenin; Esophagus; Gastric cardia; Immmunohistochemistry; p120; Prognosis

Indexed keywords

CATENIN; PROTEIN P120; UVOMORULIN; CADHERIN ASSOCIATED SRC SUBSTRATE P120; CADHERIN-ASSOCIATED SRC SUBSTRATE P120; CELL ADHESION MOLECULE; PHOSPHOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CELL ADHESION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GASTROESOPHAGEAL ADENOCARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METAPLASIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; ADENOCARCINOMA; CARDIA; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GASTRECTOMY; LYMPH NODE; LYMPHADENECTOMY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CARDIA; CELL ADHESION MOLECULES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 27644587688     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20344     Document Type: Article

References (44)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-1455.
2. Vleminckx K, Vakaet L, Jr., Mareel M, et al.: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-119.
3. Pignatelli M, Liu D, Nasim MM, et al.: Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells. Br J Cancer 1992;66:629-634.
4. Shimazui T, Schalken JA, Giroldi LA, et al.: Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res 1996;56:4154-4158.
5. Pignatelli M, Ansari TW, Gunter P, et al.: Loss of membranous E-cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994;174:243-248.
6. Kallakury BV, Sheehan CE, Winn-Deen E, et al.: Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 2001;92:2786-2795.
7. Hugh TJ, Dillon SA, Taylor BA, et al.: Cadherin-catenin expression in primary colorectal cancer: A survival analysis. Br J Cancer 1999;80:1046-1051.
8. Bukholm IK, Nesland JM, Karesen R, et al.: E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 1998;185:262-266.
9. Washington K, Chiappori A, Hamilton K, et al.: Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Mod Pathol 1998;11:805-813.
10. Krishnadath KK, Tilanus HW, van Blankenstein M, et al.: Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 1997;182:331-338.
11. Jian WG, Darnton SJ, Jenner K, et al.: Expression of E-cadherin in oesophageal carcinomas from the UK and China: Disparities in prognostic significance. J Clin Pathol 1997;50:640-644.
12. Reynolds AB, Daniel J, McCrea PD, et al.: Identification of a new catenin: The tyrosine kinase substrate p 120cas associates with E-cadherin complexes. Mol Cell Biol 1994;14:8333-8342.
13. Shibamoto S, Hayakawa M, Takeuchi K, et al.: Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J Cell Biol 1995;128:949-957.
14. Staddon JM, Smales C, Schulze C, et al.: p120, a p120-related protein (p100), and the cadherin/catenin complex. J Cell Biol 1995;130:369-381.
15. Nollet F, Kools P, van Roy F: Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000;299:551-572.
16. Daniel JM, Reynolds AB: The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or alpha-catenin. Mol Cell Biol 1995;15:4819-4824.
17. Ireton RC, Davis MA, van Hengel J, et al.: A novel role for p120 catenin in E-cadherin function. J Cell Biol 2002;159:465-476.
18. Aono S, Nakagawa S, Reynolds AB, et al.: p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells. J Cell Biol 1999;145:551-562.
19. Karayiannakis AJ, Syrigos KN, Efstathiou J, et al.: Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease. J Pathol 1998;185:413-418.
20. Karayiannakis AJ, Syrigos KN, Alexiou D, et al.: Expression patterns of the novel catenin p120cas in gastrointestinal cancers. Anticancer Res 1999;19:4401-4405.
21. Thoreson MA, Reynolds AB: Altered expression of the catenin p120 in human cancer: implications for tumor progression. Differentiation 2002;70:583-589.
22. Wijnhoven BP, Siersema PD, Hop WC, et al.: Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 1999;86:529-535.
23. Jawhari AU, Noda M, Pignatelli M, et al.: Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma. J Pathol 1999;189:180-185.
24. Powell J, McConkey CC, Gillison EW, et al. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002;102:422-427.
25. Blot WJ, Devesa SS, Kneller RW, et al.: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 199;265:1287-1289.
26. Wijnhoven BP, Louwman MW, Tilanus HW, et al.: Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002;14:115-122.
27. Lagergren J, Bergstrom R, Lindgren A, et al.: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
28. Torres C, Turner JR, Wang HH, et al.: Pathologic prognostic factors in Barrett's associated adenocarcinoma: A follow-up study of 96 patients. Cancer 1999;85:520-528.
29. Blomjous JG, Hop WC, Langenhorst BL, et al.: Adenocarcinoma of the gastric cardia. Recurrence and survival after resection. Cancer 1992;70:569-574.
30. Franchi A, Gallo O, Boddi V, et al.: Prediction of occult neck metastases in laryngeal carcinoma: Role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 1996;2:1801-1808.
31. Skoudy A, Gomez S, Fabre M, et al.: p120-catenin expression in human colorectal cancer. Int J Cancer 1996;68:14-20.
32. Dillon DA, D'Aquila T, Reynolds AB, et al.: The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Am J Pathol 1998;152:75-82.
33. Bremnes RM, Veve R, Gabrielson E, et al.: High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002;20:2417-2428.
34. Syrigos KN, Karayiannakis A, Syrigou EI, et al.: Abnormal expression of p120 correlates with poor survival in patients with bladder cancer. Eur J Cancer 1998;34:2037-2040.
35. Valizadeh A, Karayiannakis AJ, el-Hariry I, et al.: Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. Am J Pathol 1997;150:1977-1984.
36. Nawrocki B, Polette M, Van Hengel J, et al.: Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol 1998;153:1521-1530.
37. Serini G, Trusolino L, Saggiorato E, et al.: Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J Natl Cancer Inst 1996;88:442-449.
38. Matsuyoshi N, Hamaguchi M, Taniguchi S, et al.: Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 1992;118:703-714.
39. Nishimura M, Machida K, Imaizumi M, et al.: Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis. Br J Cancer 1996;74:780-787.
40. Downing JR, Reynolds AB: PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p120, a ppoOsrc transformation-associated substrate. Oncogene 1991;6:607-613.
41. Skoudy A, Llosas MD, Garcia de Herreros A: Intestinal HT-29 cells with dysfunction of E-cadherin show increased pp60src activity and tyrosine phosphorylation of p120-catenin. Biochem J 1996;317:279-284.
42. Montonen O, Aho M, Uitto J, et al.: Tissue distribution and cell type-specific expression of p!20ctn isoforms. J Histochem Cytochem 2001;49:1487-1496.
43. Aho S, Levansuo L, Montonen O, et al.: Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells. J Cell Sci 2002;115:1391-1402.
44. Mo YY, Reynolds AB: Identification of murine p 120 isoforms and heterogeneous expression of p120cas isoforms in human tumor cell lines. Cancer Res 1996;56:2633-2640.